Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data

BACKGROUND: This meta-analysis evaluated the real-world effectiveness of onabotulinumtoxinA (BOTOX®), the first preventive treatment FDA-approved specifically for chronic migraine in 2010. METHODS: We systematically reviewed onabotulinumtoxinA observational data in chronic migraine published between...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanteri-Minet, Michel, Ducros, Anne, Francois, Clement, Olewinska, Elzbieta, Nikodem, Mateusz, Dupont-Benjamin, Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693763/
https://www.ncbi.nlm.nih.gov/pubmed/36081276
http://dx.doi.org/10.1177/03331024221123058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693763/
https://www.ncbi.nlm.nih.gov/pubmed/36081276
http://dx.doi.org/10.1177/03331024221123058

Ejemplares similares